Company
Company
We are on a mission to decode the immune system and improve health.
WHY US
We are a multidisciplinary team of immunologists, engineers, drug developers, computer scientists, and entrepreneurs focused on bringing breakthrough medicines to patients.
Built from the ground up with an engineering-first approach to biology and an unparalleled understanding of the immune system, we know we’re up for the challenge. Immunai was founded in December 2018. Our global team spans New York City, Tel Aviv, San Francisco, Prague, and Zurich.
In March 2021, Immunai acquired Dropprint Genomics, a Y-combinator backed, single cell genomics software company based in San Francisco. Dropprint’s database of immune cells further expanded AMICA.
In July 2021, Immunai made the transformational acquisition of NEBION, a world leader in biocuration and data integration. NEBION has structured hundreds of thousands of samples and millions of cells across thousands of public studies under a unified clinical ontology, all powered by bespoke expert curation. This data has supercharged AMICA’s growth and expanded our target discovery efforts into a wide range of inflammatory and oncological settings.
Immunai
core values
Aim High, Think Big, Take Risks
We strive to transform patients’ lives. Our ambition aims beyond incremental improvements and convention. We take calculated risks to achieve exponential outcomes and learn quickly from each setback.Insist on the Highest Standards
Our success is dependent on consistently operating with the highest standards. We hire, develop, and promote world-class talent who are curious and continually strive to learn. We pride ourselves on collaborating with the best partners to achieve transformative results.
Team Above I
Operate with a no-nonsense, team-oriented attitude. We solve complex problems together as a multidisciplinary team. We check our ego at the door, and value colleagues who care about the team’s success, support each other, and use continuous feedforward to improve ourselves and others.Have Backbone; Disagree and Commit
We spread an atmosphere of trust. We feel safe and make others feel safe to disagree and challenge ideas yet commit to the ultimate decision.Strive to Win
We are relentlessly focused on delivering high impact, successful results. We are biased toward action, plan well, and honor our commitments.
Our employees
Meet the team
Noam Solomon, PhD
CEO & Co-Founder
Tali Raveh-Sadka, PhD
VP, Computational R&D
Sen Zhang
VP, Product
Adeeb Rahman, PhD
VP, Single Cell Immunology
Evan Zisholtz
VP, Corporate Development
Roy Cohen
VP, Finance
Elisha Nathan
VP, Strategic Alliances
Philip Zimmermann
VP, Business Development Europe
Galit Yahalom
VP, Operations
Noam Solomon, PhD
CEO & Co-Founder
Luis Voloch
Co-Founder
Danny Wells, PhD
Scientific Co-Founder
Ansuman Satpathy, MD, PhD
Scientific Co-Founder
Dan Littman, MD, PhD
Scientific Co-Founder
Robert S. Langer, PhD
Mark Jacobstein
Regina Barzilay, PhD
Stanley Frankel, MD
Caroline Uhler, PhD
Rahul Satija, PhD
Tony Ho, MD
Prof. Ido Amit
Jimmie Ye, PhD
Life at Immunai
Work life
At Immunai, you’ll have an opportunity to work with great people, tackle massive challenges and make an impact on the health of patients worldwide.